Selective Targeting to Glioma with Nucleic Acid Aptamers.
Malignant glioma is characterised by a rapid growth rate and high capacity for invasive infiltration to surrounding brain tissue; hence, diagnosis and treatment is difficult and patient survival is poor. Aptamers contribute a promising and unique technology for the in vitro imaging of live cells and...
Main Authors: | Shraddha Aptekar, Mohit Arora, Clare Louise Lawrence, Robert William Lea, Katherine Ashton, Tim Dawson, Jane Elizabeth Alder, Lisa Shaw |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0134957 |
Similar Items
-
Nucleic Acid Aptamers in Nanotechnology
by: Valentina V. Sinitsyna, et al.
Published: (2022-05-01) -
Recent Progress and Opportunities for Nucleic Acid Aptamers
by: Jonghoe Byun
Published: (2021-02-01) -
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
by: Zhaoying Fu, et al.
Published: (2020-04-01) -
Editorial: Nucleic acid-based aptamers in therapeutics and diagnostics
by: Anna Aviñó, et al.
Published: (2024-01-01) -
Nucleic Acid Aptamer-Based Biosensors: A Review
by: Beatriz Sequeira-Antunes, et al.
Published: (2023-12-01)